Ready-to-market medical device for assessing - via the eye - exposure to neurotoxins, cyanide, and low level radiation. Future products include assessment of mild TBI and other health conditions, including diabetic diseases of the eye.
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of EyeMarker Systems plus 4812 other startups.